Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 387-390

  Przybylowski, P ^a   Malyszko, J S ^a   MacDougall, I C ^a   Malyszko, J ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTEIN; TRANSFERRIN RECEPTOR;

ADULT; ANEMIA; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE COUNT; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANEMIA; ANTIMICROBIAL CATIONIC PEPTIDES; C-REACTIVE PROTEIN; CYSTATIN C; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; IRON; MALE; MIDDLE AGED; PREVALENCE; TOR SERINE-THREONINE KINASES;

EID: 84873293006     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.02.040     Document Type: Article

References (23)

1. I. Gotsman, S. Rubonivich, T. Azaz-Livshits Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome Isr Med Assoc J 10 2008 214 218
2. D.S. Silverberg, D. Wexler, Blum The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations J Am Coll Cardiol 35 2000 1737 1744
3. World Health Organization Nutritional anaemias: report of a WHO Scientific Group World Health Organ Tech Rep Ser 405 1968 5
4. B.L. Kasiske, M.A. Vazquez, W.E. Harmon Recommendations for the outpatient surveillance of renal transplant recipients American Society of Transplantation J Am Soc Nephrol 11 Suppl 15 2000 S1 S86
5. P. Przybylowski, J. Malyszko, J.S. Malyszko Anemia and its predictors in heart transplant recipients Transplant Proc 41 2009 3228
6. A.B. Taegtmeyer, P. Rogers, J.B. Breen The effects of pre- and post-transplant anemia on 1-year survival after cardiac transplantation J Heart Lung Transplant 27 2008 394 399
7. G.A. Bergen, P.E. Sakalosky, J.T. Sinnott Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient J Heart Lung Transplant 15 1996 843
8. T. Ganz Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 102 2003 783 788
9. G. Nicolas, C. Chauvet, L. Viatte The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation J Clin Invest 110 2002 1037 1044
10. E. Nemeth, E.V. Valore, M. Territo Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 101 2003 2461
11. A. Maiorano, G. Stallone, A. Schena Sirolimus interferes with iron homeostasis in renal transplant recipients Transplantation 82 2006 908 912
12. A.S. Levey, L.A. Stevens, C.H. Schmid CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
13. Modification of Diet in Renal Disease Study Group Creatinine filtration, secretion and excretion during progressive renal disease Kidney Int 36 1989 S73
14. D.W. Cockcroft, M.H. Gaul Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
15. J. Malyszko, H. Bachorzewska-Gajewska, J.S. Malyszko Prevalence of chronic kidney disease (CKD) and anemia in patients with coronary artery disease with normal serum creatinine, undergoing percutaneous coronary interventions (PCI), in relation to New York Heart Association (NYHA) class IST Med Assoc J 12 2010 489 493
16. E.A. Jankowska, P. Rozentryt, A. Witkowska Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur Heart J 31 2010 1872
17. T.C. Mix, W. Kazmi, S. Khan Anemia: a continuing problem following kidney transplantation Am J Transplant 3 2003 1426 1433
18. A. Al-Uzri, P.D. Yorgin, P.J. Kling Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis Pediatr Transplant 7 2003 253 264
19. J.J. Augustine, T.C. Knauss, J.A. Schulak Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients Am J Transplant 4 2004 2001 2006
20. P. Friend, G. Russ, R. Oberbauer Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function Transpl Int 20 2007 754 760
21. O. Thaunat, C. Beaumont, L. Chatenoud Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state Transplantation 80 2005 1212 1219
22. S. Sofroniadou, T. Kassimatis, D. Goldsmith Anemia, microcytosis and sirolimus - is iron the missing link? Nephrol Dial Transplant 25 2010 1667 1675
23. S. Al-Khoury, N. Shah, B. Afzali Post-transplantation anemia in adult and paediatric renal allograft recipients-Guy's Hospital experience Nephrol Dial Transplant 21 2006 1974 1980